Algatech Licenses Rights to Beta Glucan Production Technology
09/08/2019
Algatech intends to launch several products using the algae-derived beta glucan, which will expand Algatech’s existing product offering and support its mission to develop commercial, microalgae-based products.
Algatech has announced the appointment of Mr. Doron Safrai as its new Chief Executive Officer. Mr. Safrai’s appointment comes at an important moment in the company’s development as the company now looks forward to the launch of a new product related to the use of β-1,3-glucan derived from microalgae Euglena gracilis.
The growing demand for the fucoxanthin found in Algatech’s FucoVital has led to a tripling of Algatech’s fucoxanthin production capability. This is a significant step forward in meeting the growing demand for this powerful natural ingredient.